metastatic glioblastoma (mGB) - 1st line (L1) | |
metastatic glioblastoma (mGB) - 1st line (L1) | |
nivolumab alone | Checkmate 143 |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -